DE69029398T2 - Hemmung von padgem-vermittelter zellbindung - Google Patents
Hemmung von padgem-vermittelter zellbindungInfo
- Publication number
- DE69029398T2 DE69029398T2 DE69029398T DE69029398T DE69029398T2 DE 69029398 T2 DE69029398 T2 DE 69029398T2 DE 69029398 T DE69029398 T DE 69029398T DE 69029398 T DE69029398 T DE 69029398T DE 69029398 T2 DE69029398 T2 DE 69029398T2
- Authority
- DE
- Germany
- Prior art keywords
- padgem
- inhibition
- cell binding
- mediated cell
- cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/7056—Lectin superfamily, e.g. CD23, CD72
- C07K14/70564—Selectins, e.g. CD62
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2851—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the lectin superfamily, e.g. CD23, CD72
- C07K16/2854—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the lectin superfamily, e.g. CD23, CD72 against selectins, e.g. CD62
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US42488689A | 1989-10-20 | 1989-10-20 | |
PCT/US1990/006101 WO1991006632A1 (en) | 1989-10-20 | 1990-10-22 | Inhibition of padgem-mediated cell binding |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69029398D1 DE69029398D1 (de) | 1997-01-23 |
DE69029398T2 true DE69029398T2 (de) | 1997-04-10 |
Family
ID=23684279
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69029398T Expired - Lifetime DE69029398T2 (de) | 1989-10-20 | 1990-10-22 | Hemmung von padgem-vermittelter zellbindung |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP0496832B1 (de) |
JP (1) | JPH05504470A (de) |
AT (1) | ATE146218T1 (de) |
CA (1) | CA2067250C (de) |
DE (1) | DE69029398T2 (de) |
DK (1) | DK0496832T3 (de) |
ES (1) | ES2097765T3 (de) |
GR (1) | GR3022011T3 (de) |
WO (1) | WO1991006632A1 (de) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5800815A (en) * | 1903-05-05 | 1998-09-01 | Cytel Corporation | Antibodies to P-selectin and their uses |
US5464778A (en) * | 1989-03-08 | 1995-11-07 | Board Of Regents Of The University Of Oklahoma | Glycoprotein ligand for P-selectin and methods of use thereof |
US5753631A (en) * | 1990-06-15 | 1998-05-19 | Cytel Corporation | Intercellular adhesion mediators |
WO1992001718A2 (en) * | 1990-07-17 | 1992-02-06 | Board Of Regents Of The University Of Oklahoma | Functionally active selectin-derived peptides and ligand for gmp-140 |
US6309639B1 (en) | 1991-02-05 | 2001-10-30 | The Board Of Regents Of The University Of Oklahoma | Method for inhibiting an inflammatory response using antibodies to P-selectin glycoprotein ligand |
US6124267A (en) * | 1991-02-05 | 2000-09-26 | Southpac Trust Internationals, Inc. | O-glycan inhibitors of selectin mediated inflammation derived from PSGL-1 |
US5807745A (en) * | 1991-03-11 | 1998-09-15 | New England Medical Center Hospitals, Inc. | Method of inhibiting PADGEM-mediated or ELAM-1-mediated leukocyte adhesion using an inhibitor comprising a Lex core component |
WO1992016612A2 (en) * | 1991-03-11 | 1992-10-01 | New England Medical Center Hospitals, Inc. | Method of inhibiting padgem-mediated interactions using an inhibitor comprising a 2,6 sialic acid component |
US5646123A (en) * | 1991-06-10 | 1997-07-08 | Alberta Research Council | Time dependent administration of oligosaccharide glycosides related to blood group determinants having a type I or type II core structure in reducing inflammation in a sensitized mammal arising form exposure to an antigen |
WO1992022301A1 (en) * | 1991-06-10 | 1992-12-23 | Alberta Research Council | Immunosuppressive and tolerogenic oligosaccharide derivatives |
EP0608260A1 (de) | 1991-09-10 | 1994-08-03 | Centocor, Inc. | Von selectinen abgeleitete peptide zur behandlung von entzündungen |
AU678757B2 (en) * | 1991-09-30 | 1997-06-12 | Biogen, Inc. | Inhibition of vascular narrowing using anti-padgem antibodies |
EP0602194A1 (de) * | 1991-12-18 | 1994-06-22 | Centocor, Inc. | Peptid-inhibitoren von die durch selektine verursachten entzundungen |
US6033667A (en) * | 1992-05-05 | 2000-03-07 | Cytel Corporation | Method for detecting the presence of P-selectin |
DE69332881T2 (de) * | 1992-05-05 | 2004-01-29 | Aeres Biomedical Ltd | Antikörper gegen p-selectin und ihre verwendung |
ES2168095T3 (es) * | 1992-05-11 | 2002-06-01 | Corvas Int Inc | Inhibidores de neutrofilos procedentes de nematodos. |
ATE256182T1 (de) * | 1992-10-23 | 2003-12-15 | Inst Genetics Llc | Neuartiges p- selectin ligandenprotein |
US5843707A (en) * | 1992-10-23 | 1998-12-01 | Genetics Institute, Inc. | Nucleic acid encoding a novel P-selectin ligand protein |
US6277975B1 (en) | 1992-10-23 | 2001-08-21 | Genetics Institute, Inc. | Fusions of P-selectin ligand protein and polynucleotides encoding same |
AU681369B2 (en) * | 1992-11-16 | 1997-08-28 | Board Of Regents Of The University Of Oklahoma, The | Glycoprotein ligand for P-selectin and methods of use thereof |
EP0804235A4 (de) * | 1993-05-04 | 2001-09-19 | Aeres Biomedical Ltd | Antikörper gegen p-selectin und ihre verwendungen |
AU2361395A (en) * | 1994-04-28 | 1995-11-29 | Genetics Institute Inc. | Novel P-selectin ligand protein |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL88308A0 (en) * | 1987-11-17 | 1989-06-30 | Scripps Clinic Res | Peptides that block the binding of von willebrand factor |
WO1992001718A2 (en) * | 1990-07-17 | 1992-02-06 | Board Of Regents Of The University Of Oklahoma | Functionally active selectin-derived peptides and ligand for gmp-140 |
-
1990
- 1990-10-22 ES ES90917479T patent/ES2097765T3/es not_active Expired - Lifetime
- 1990-10-22 DK DK90917479.9T patent/DK0496832T3/da active
- 1990-10-22 WO PCT/US1990/006101 patent/WO1991006632A1/en active IP Right Grant
- 1990-10-22 CA CA002067250A patent/CA2067250C/en not_active Expired - Lifetime
- 1990-10-22 JP JP3500423A patent/JPH05504470A/ja active Pending
- 1990-10-22 EP EP90917479A patent/EP0496832B1/de not_active Expired - Lifetime
- 1990-10-22 AT AT90917479T patent/ATE146218T1/de not_active IP Right Cessation
- 1990-10-22 DE DE69029398T patent/DE69029398T2/de not_active Expired - Lifetime
-
1996
- 1996-12-12 GR GR960403237T patent/GR3022011T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
EP0496832B1 (de) | 1996-12-11 |
CA2067250A1 (en) | 1991-04-21 |
CA2067250C (en) | 2008-06-17 |
DE69029398D1 (de) | 1997-01-23 |
EP0496832A1 (de) | 1992-08-05 |
EP0496832A4 (en) | 1993-02-17 |
DK0496832T3 (da) | 1996-12-30 |
JPH05504470A (ja) | 1993-07-15 |
WO1991006632A1 (en) | 1991-05-16 |
GR3022011T3 (en) | 1997-03-31 |
ATE146218T1 (de) | 1996-12-15 |
ES2097765T3 (es) | 1997-04-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69029398T2 (de) | Hemmung von padgem-vermittelter zellbindung | |
DE3783042D1 (de) | System zur automatisierung von testen. | |
DE68901632D1 (de) | Reaktionsgefaess zur durchfuehrung von aufeinanderfolgenden analytischen testen. | |
IT8019675A0 (it) | Procedimento per rivelare ligandi in campioni di prova e relativo reagente analitico. | |
DE3787771T2 (de) | Elektrochemische Analysenmethode. | |
DE3671105D1 (de) | Automatischer analysator mit freiem zugang zur probe. | |
DE3689856D1 (de) | Analyseverfahren und vorrichtung für biologische specimen. | |
ATE76508T1 (de) | Vorrichtung zur feststellung von okkultem blut. | |
ES511797A0 (es) | "metodo para ensayar reacciones antigeno-anticuerpo". | |
DE3582758D1 (de) | Verfahren und anordnung zur entdeckung von schmuggelsubstanz. | |
DE59109048D1 (de) | Inhibitoren zur antikoagulierenden Vorbehandung von Blutproben | |
NO890867L (no) | Fluidum-proevetaker, saerlig for benyttelse i en oljebroenn. | |
NO864113D0 (no) | Fremgangsmaate for immonoassay, samt analysesett for dens utfoerelse. | |
DE68914617T2 (de) | Nachweisvorrichtung für Kathodenlumineszenzanalyse. | |
ES509142A0 (es) | Procedimiento para determinar la presencia de una analito en una muestra sospechosa de contenerlo. | |
DE3750084D1 (de) | Anordnung für Einführung von Vorrissen in Keramikproben. | |
DE3853560D1 (de) | Analytisches Element zur Vollblutuntersuchung. | |
DE69023426D1 (de) | Behälter für Flüssigkeitsproben. | |
DE69021912T2 (de) | Probeneinspritzzelle. | |
PT77153B (de) | Drehzapfenlager fuer tueren insbesondere fuer pendeltueren | |
DE69007155T2 (de) | Automatisierte Schnittentwicklungsanalyse von mehrfachen Proben. | |
DE3778471D1 (de) | Testreagens zur bestimmung von amylase. | |
ES2166996T3 (es) | Metodo y reactivo para controlar los niveles en sangre de compuestos antiplaquetarios. | |
DE3852498T2 (de) | Enzymtest für biologische substanzen. | |
DE3586511D1 (de) | Diagnostisches reagenz zur bestimmung von harnstickstoff. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8327 | Change in the person/name/address of the patent owner |
Owner name: NEW ENGLAND MEDICAL CENTER HOSPITALS, INC., BOSTON |
|
8364 | No opposition during term of opposition |